info_outline
Michael Quirmbach CEO, CordenPharma
06/12/2025
Michael Quirmbach CEO, CordenPharma
Welcome to this episode! We Talked to Michaels Quirmbach CEO of CordenPharma and discussed thir ambitious plans and recent strategic moves. Michael will share insights on their record-breaking €1 billion investment over the next three years to expand peptide manufacturing across Europe and the US, including a major greenfield site outside Basel, Switzerland. We’ll explore what motivated this huge push, why Basel was chosen, and what sets CordenPharma apart in the competitive GLP-1 space. Plus, we'll get a sneak peek into other platform expansions and updates on CordenPharma’s sustainability and ESG initiatives. Stay tuned!
/episode/index/show/276f4254-9be6-4ac7-9cb1-f5b2b1991f09/id/36967600